Magnus Björkholm

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells

Nikita Popov, Qian Wang, M. Henriksson, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models

Paul W Dickman, Kamila Czene, Paul C Lambert, 2012, BMC Medical Research Methodology.

Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.

Sigurdur Y Kristinsson, M. Björkholm, I. Turesson, 2009, Clinical lymphoma & myeloma.

Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern

Ingemar Ernberg, I. Ernberg, A. Porwit, 2007, Leukemia & lymphoma.

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Paul W Dickman, Paul C Lambert, Hannah Bower, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Bengt Simonsson, Olle Linder, U. Olsson‐Strömberg, 2004, The hematology journal : the official journal of the European Haematology Association.

High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes

Birgitta Sander, B. Sander, J. Flygare, 2009, BMC Immunology.

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Ulf Persson, Katarina Steen Carlsson, Leif Stenke, 2015, Leukemia and Lymphoma.

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.

John Myhre, Hans Hagberg, Hannu Pertovaara, 2003, Blood.

with follicular lymphoma High expression of cyclin B 1 predicts a favorable outcome in patients

Erik Björck, Sara Ek, M. Ehinger, 2004 .